Nucleoside and nucleotide analogues
Medchemexpress LLC Rp-cAMPS sodium salt | 142439-94-9 | 99.7% | 367.25 | C10H11N5NaO5PS | 5 MG
Rp-cAMPS sodium salt is a cAMP analog that competitively antagonizes cAMP-dependent protein kinase A (PKA) I and II and is resistant to hydrolysis by phosphodiesterases, intended for biochemical and cell signaling research applications.
- High purity (≈99.7%) suitable for biochemical assays.
- Molecular formula C10H11N5NaO5PS and molecular weight 367.25 g/mol.
- Resistant to hydrolysis by phosphodiesterases.
- Reported Ki values ~6.05 μM (PKA I) and ~9.75 μM (PKA II).
- Solid, white to pink appearance; available as solid or solution (10 mM in DMSO).
- Storage: -20°C sealed; in solvent -80°C (6 months) or -20°C (1 month).
Selleck Chemical LLC Lamivudine S1706-1g
Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor used for treatment of chronic HBV and HIV/AIDS It works by blocking the HIV reverse transcriptase and hepatitis B virus polymerase
![eMolecules Medchem Express / Rp-cAMPS (sodium salt) / 1mg / 632433127 / HY-100530D / / 142439-94-9 / [null] / 367.250 / C10H11N5NaO5PS](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502472106.JPG-250.jpg)
eMolecules Medchem Express / Rp-cAMPS (sodium salt) / 1mg / 632433127 / HY-100530D / / 142439-94-9 / [null] / 367.250 / C10H11N5NaO5PS
Medchem Express / Rp-cAMPS (sodium salt) / 1mg / 632433127 / HY-100530D / / 142439-94-9 / [null] / 367.250 / C10H11N5NaO5PS
Medchemexpress LLC Lamivudine | 134678-17-4 | 100 MG
Lamivudine (BCH-189) is an orally active nucleoside reverse transcriptase inhibitor (NRTI). It can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus. Lamivudine salicylate can penetrate the central nervous system (CNS). It appears as a solid and has a molecular weight of 229.26. Its identified uses include laboratory chemicals and the manufacture of substances.
- Orally active nucleoside reverse transcriptase inhibitor
- Inhibits HIV reverse transcriptase 1/2
- Inhibits reverse transcriptase of hepatitis B virus
- Salicylate form can penetrate the CNS
- Solid appearance
- Molecular weight of 229.26
Medchemexpress LLC Lamivudine | 134678-17-4 | 99.9% | 500 MG
Lamivudine (BCH-189) is an orally active nucleoside reverse transcriptase inhibitor (NRTI). It is capable of inhibiting both HIV reverse transcriptase 1/2 and the reverse transcriptase of hepatitis B virus. Additionally, lamivudine salicylate has the ability to penetrate the central nervous system (CNS).
- Orally active nucleoside reverse transcriptase inhibitor (NRTI)
- Inhibits HIV reverse transcriptase 1/2
- Inhibits reverse transcriptase of hepatitis B virus
- Salicylate form can penetrate the CNS
Apexbio Technology LLC Lamivudine 134678-17-4 50mg
Lamivudine is a nucleoside analog that acts primarily as a reverse transcriptase inhibitor disrupting viral replication by interfering with RNA-dependent DNA polymerase activity It inhibits human immunodeficiency virus type 1 (HIV-1) reverse transcriptase with an IC50 value of approximately 0 316 M Lamivudine also suppresses replication of simian retrovirus (SRV-1 and SRV-2) while exhibiting negligible activity on foamy viruses and amphotropic murine leukemia virus (MLV-A) Due to its antiviral mechanism and dual inhibitory effect against both HIV-1 and hepatitis B virus (HBV) lamivudine is frequently utilized in research involving retroviral infection models particularly HIV-1 and HBV coinfection studies to evaluate viral dynamics antiviral efficacy and biochemical responses
- 1
- 2